AU
UK
CA
US
IND
NZ
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As legendary investor Warren Buffett prepares to step down as CEO of Berkshire Hathaway Inc. (NYSE:BRK) (NYSE:BRK) by the end of 2025, a 13F filing released on …
(This May 17 story is repeated without any changes to the text) WASHINGTON (Reuters) - Families of some of the 346 people killed in two fatal Boeing 737 MAX crashes plan to object to a tentative nonprosecution agreement between the planemaker and the U.S. …
ROME (Reuters) -Germany does not expect Italy's UniCredit to launch a full bid for German rival Commerzbank at present, German Chancellor Friedrich Merz said on Saturday. UniCredit disclosed last year that it had built a web of financial transactions through derivatives to secure a …
Cathie Wood, founder and chief of Ark Investment Management, is best known for backing cutting-edge tech like AI and robotics, with most of her investments focused on U.S. companies. But this week, she made a move in China, picking up $2.7 million worth of …
Meta (NASDAQ:META) is reportedly stepping up its game to land big government defense contracts, and CEO Mark Zuckerberg is leading the charge. Meta’s Military Makeover According to Forbes, the tech giant is actively recruiting former Pentagon and national security officials to help pitch its …
Oppenheimer raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $19 from $17 and keeps a Perform rating on the shares. The firm sees the Delaware court’s verdict in favor of Acadia as consistent with its expectations for Nuplazid intellectual property protection while …
BMO Capital analyst Evan Seigerman notes that a U.S. district court issued a ruling in favor of Acadia Pharmaceuticals (ACAD) in their Nuplazid patent infringement lawsuit with Aurobindo, confirming today that Aurobindo infringed on claims 4 and 5 of Acadia’s 11,452,721 U.S. formulation patent. …
Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this daily recap compiled by The Fly: Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI …
AppLovin recently experienced a significant share price increase of 58% over the past month, moving distinctly beyond the broader market's 5% increase over the last week. This notable performance came after the company reported strong Q1 earnings, with sales and net income showing substantial …
Leerink analyst Joseph Schwartz notes BioMarin (BMRN) believes INZ-701 could be a $400M-$600M opportunity at peak, making it a nice addition to the company’s ERT portfolio; this is likely the first business development deal in 2025. Before market open on Friday, BioMarin disclosed a …
Please wait processing your request...